Literature DB >> 29410378

New insights into NAFLD and subclinical coronary atherosclerosis.

Lisa B VanWagner1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29410378      PMCID： PMC5903205          DOI： 10.1016/j.jhep.2018.01.023

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  18 in total

1.  2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Philip Greenland; Joseph S Alpert; George A Beller; Emelia J Benjamin; Matthew J Budoff; Zahi A Fayad; Elyse Foster; Mark A Hlatky; John McB Hodgson; Frederick G Kushner; Michael S Lauer; Leslee J Shaw; Sidney C Smith; Allen J Taylor; William S Weintraub; Nanette K Wenger; Alice K Jacobs
Journal:  Circulation       Date:  2010-11-15       Impact factor: 29.690

Review 2.  Nonalcoholic fatty liver disease is associated with coronary artery calcification: A systematic review and meta-analysis.

Authors:  Veeravich Jaruvongvanich; Kamonkiat Wirunsawanya; Anawin Sanguankeo; Sikarin Upala
Journal:  Dig Liver Dis       Date:  2016-09-17       Impact factor: 4.088

3.  Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up.

Authors:  Mattias Ekstedt; Hannes Hagström; Patrik Nasr; Mats Fredrikson; Per Stål; Stergios Kechagias; Rolf Hultcrantz
Journal:  Hepatology       Date:  2015-03-23       Impact factor: 17.425

4.  Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population.

Authors:  Maria Stepanova; Zobair M Younossi
Journal:  Clin Gastroenterol Hepatol       Date:  2012-01-13       Impact factor: 11.382

5.  Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease: Mendelian randomization and meta-analysis of 279 013 individuals.

Authors:  Bo Kobberø Lauridsen; Stefan Stender; Thomas Skårup Kristensen; Klaus Fuglsang Kofoed; Lars Køber; Børge G Nordestgaard; Anne Tybjærg-Hansen
Journal:  Eur Heart J       Date:  2018-02-01       Impact factor: 29.983

Review 6.  Hypercoagulation and thrombophilia in nonalcoholic fatty liver disease: mechanisms, human evidence, therapeutic implications, and preventive implications.

Authors:  Patrick G Northup; Curtis K Argo; Neeral Shah; Stephen H Caldwell
Journal:  Semin Liver Dis       Date:  2012-03-13       Impact factor: 6.115

7.  Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey.

Authors:  Jeffrey C Sirota; Kim McFann; Giovanni Targher; Richard J Johnson; Michel Chonchol; Diana I Jalal
Journal:  Metabolism       Date:  2012-10-02       Impact factor: 8.694

8.  The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD.

Authors:  Paul Angulo; Jason M Hui; Giulio Marchesini; Ellisabetta Bugianesi; Jacob George; Geoffrey C Farrell; Felicity Enders; Sushma Saksena; Alastair D Burt; John P Bida; Keith Lindor; Schuyler O Sanderson; Marco Lenzi; Leon A Adams; James Kench; Terry M Therneau; Christopher P Day
Journal:  Hepatology       Date:  2007-04       Impact factor: 17.425

9.  2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).

Authors:  Massimo F Piepoli; Arno W Hoes; Stefan Agewall; Christian Albus; Carlos Brotons; Alberico L Catapano; Marie-Therese Cooney; Ugo Corrà; Bernard Cosyns; Christi Deaton; Ian Graham; Michael Stephen Hall; F D Richard Hobbs; Maja-Lisa Løchen; Herbert Löllgen; Pedro Marques-Vidal; Joep Perk; Eva Prescott; Josep Redon; Dimitrios J Richter; Naveed Sattar; Yvo Smulders; Monica Tiberi; H Bart van der Worp; Ineke van Dis; W M Monique Verschuren; Simone Binno
Journal:  Eur Heart J       Date:  2016-05-23       Impact factor: 29.983

10.  Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis.

Authors:  Giovanni Targher; Christopher D Byrne; Amedeo Lonardo; Giacomo Zoppini; Corrado Barbui
Journal:  J Hepatol       Date:  2016-05-17       Impact factor: 25.083
View more
  5 in total

Review 1.  Non-alcoholic fatty liver disease and Atherosclerosis at a crossroad: The overlap of a theory of change and bioinformatics.

Authors:  Guglielmo M Trovato
Journal:  World J Gastrointest Pathophysiol       Date:  2020-05-12

Review 2.  Network Modeling Approaches and Applications to Unravelling Non-Alcoholic Fatty Liver Disease.

Authors:  Montgomery Blencowe; Tilan Karunanayake; Julian Wier; Neil Hsu; Xia Yang
Journal:  Genes (Basel)       Date:  2019-11-24       Impact factor: 4.096

3.  Chronic renal dysfunction in cirrhosis: A new frontier in hepatology.

Authors:  Ramesh Kumar; Rajeev Nayan Priyadarshi; Utpal Anand
Journal:  World J Gastroenterol       Date:  2021-03-21       Impact factor: 5.742

Review 4.  The Interplay of Vitamin D Deficiency and Cellular Senescence in The Pathogenesis of Obesity-Related Co-Morbidities.

Authors:  Abdulhadi Bima; Basmah Eldakhakhny; Dina Nuwaylati; Abrar Alnami; Mohammed Ajabnoor; Ayman Elsamanoudy
Journal:  Nutrients       Date:  2021-11-17       Impact factor: 5.717

Review 5.  Emerging Role of Nuclear Receptors for the Treatment of NAFLD and NASH.

Authors:  Ryan D Welch; Cyrielle Billon; McKenna Losby; Gonzalo Bedia-Diaz; Yuanying Fang; Amer Avdagic; Bahaa Elgendy; Thomas P Burris; Kristine Griffett
Journal:  Metabolites       Date:  2022-03-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.